One-Year Safety of Olodaterol Once Daily via Respimat (R) in Patients with GOLD 2-4 Chronic Obstructive Pulmonary Disease: Results of a Pre-Specified Pooled Analysis

DSpace Repository

One-Year Safety of Olodaterol Once Daily via Respimat (R) in Patients with GOLD 2-4 Chronic Obstructive Pulmonary Disease: Results of a Pre-Specified Pooled Analysis

Author: McGarvey, Lorcan; Niewoehner, Dennis; Magder, Sheldon; Sachs, Paul; Tetzlaff, Kay; Hamilton, Alan; Korducki, Lawrence; Bothner, Ulrich; Vogelmeier, Claus; Koch, Andrea; Ferguson, Gary T.
Tübinger Autor(en):
Tetzlaff, Kay
Published in: Copd - Journal of Chronic Obstructive Pulmonary Disease (2015), Bd. 12, H. 5, S. 484-493
Verlagsangabe: Taylor & Francis Inc
Language: English
Full text: http://dx.doi.org/10.3109/15412555.2014.991864
ISSN: 1541-2555
DDC Classifikation: 610 - Medicine and health
Dokumentart: Artikel
Show full item record

This item appears in the following Collection(s)